Bioequivalence between two serum-free recombinant factor VIII preparations (N8 and ADVATEâ)-an open-label, sequential dosing pharmacokinetic study in patients with severe haemophilia A - Martinowitz, U; Bjerre, J; Brand, B (Haemophilia, 2011)
et al.